HPRT1 and myeloid sarcoma: MS patients’ HPRT-deficient T-lymphocyte clones, but not wild-type clones, were potentially autoreactive, i.e. proliferated in response to myelin autoantigen [18] and a higher HPRT-deficient T lymphocyte frequency was reported in MS patients as compared to controls [19].